Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer. [electronic resource]
- Breast (Edinburgh, Scotland) Feb 2012
- 40-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-3080
10.1016/j.breast.2011.07.015 doi
Aged Androstadienes--therapeutic use Aromatase Inhibitors--therapeutic use Body Mass Index Breast Neoplasms--drug therapy Chemotherapy, Adjuvant Female Humans Middle Aged Neoadjuvant Therapy Postmenopause Preoperative Care Treatment Outcome